Format

Send to

Choose Destination
Methods Mol Biol. 2014;1187:15-28. doi: 10.1007/978-1-4939-1139-4_2.

Genetic screens to identify new Notch pathway mutants in Drosophila.

Author information

1
Department of Neurology, Jan and Dan Duncan Neurological Institute, Baylor College of Medicine, 1250 Moursund St. Ste. 1150, Houston, TX, 77030, USA, giagtzog@bcm.edu.

Abstract

Notch signaling controls a wide range of developmental processes, including proliferation, apoptosis, and cell fate specification during both development and adult tissue homeostasis. The functional versatility of the Notch signaling pathway is tightly linked with the complexity of its regulation in different cellular contexts. To unravel the complexity of Notch signaling, it is important to identify the different components of the Notch signaling pathway. A powerful strategy to accomplish this task is based on genetic screens. Given that the developmental context of signaling is important, these screens should be customized to specific cell populations or tissues. Here, I describe how to perform F1 clonal forward genetic screens in Drosophila to identify novel components of the Notch signaling pathway. These screens combine a classical EMS (ethyl methanesulfonate) chemical mutagenesis protocol along with clonal analysis via FRT-mediated mitotic recombination. These F1 clonal screens allow rapid phenotypic screening within clones of mutant cells induced at specific developmental stages and in tissues of interest, bypassing the pleiotropic effects of isolated mutations. More importantly, since EMS mutations have been notoriously difficult to map to specific genes in the past, I briefly discuss mapping methods that allow rapid identification of the causative mutations.

PMID:
25053478
DOI:
10.1007/978-1-4939-1139-4_2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center